Literature DB >> 1678629

Upper gastrointestinal bleeding. With special reference to blood transfusion.

A E Henriksson1, J O Svensson.   

Abstract

Upper gastrointestinal haemorrhage in 978 unselected patients during a 9-year period was reviewed in regard to incidence, diagnosis, treatment and mortality rate. The annual incidence was 1/1,000 of the catchment population. The source of bleeding was established in 89% of cases. Peptic ulcer accounted for 53% of total admissions. Blood transfusion was given only when the haemoglobin was less than 8.0 g/dl or if the patient was in shock. Emergency surgery was performed on only 31 patients (3%). The perioperative mortality was 13% and the overall mortality 6%. It is concluded that current treatment policy resulted in low rates of operation and mortality in these unselected cases of upper gastrointestinal haemorrhage. The results support the theory that a hypercoagulable state in gastrointestinal bleeding is counteracted by citrated stored blood.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678629

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  3 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

2.  The impact of HIV testing on blood utilization in the intensive care unit in patients with gastrointestinal bleeding.

Authors:  M E Ravry; H L Paz
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

3.  Patient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs.

Authors:  Kenneth Henriksson; Jesper From; Georgios Stratelis
Journal:  Patient Prefer Adherence       Date:  2014-11-18       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.